U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07411716) titled 'Pediatric Evaluation and Registry for Liver Cholestasis in Canada' on Feb. 09.
Brief Summary: The purpose of this study is to create a national, multi-centre registry for children with Alagille syndrome (ALGS) and Genetic Intrahepatic Cholestasis (GIC) that follows participants long-term, ensuring standardized, high-quality data capture across all participating pediatric hepatology centres.
Inclusion criteria:
* Pediatric participants (<18 years old) with genetically confirmed or clinically diagnosed ALGS or any of the various subtypes of GIC, each associated with a distinct genetic mutation: A. PFIC Type 1 (FIC1 Deficiency) - Mut...